David Pyott

“On April 14, 2026, David E.I. Pyott, a Class I director on the Board of Directors (the "Board") of Pliant Therapeutics, Inc. (the "Company") and a member of the Audit Committee and the Nominating and Corporate Governance Committee of the Board, notified the Chief Executive Officer of the Company, Chairman of the Board, and Chair of the Nominating and Corporate Governance Committee of his retirement from the Board and all committees thereof, effective as of the Company's 2026 Annual Meeting of Stockholders (the "Annual Meeting").”